COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: Evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression
- 15 October 2005
- journal article
- Published by Elsevier in NeuroImage
- Vol. 28 (1) , 185-193
- https://doi.org/10.1016/j.neuroimage.2005.05.030
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on mRNA, Protein, and Enzyme Activity in Postmortem Human BrainAmerican Journal of Human Genetics, 2004
- [3h]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brainNeuroscience, 2003
- Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human BrainJournal of Neuroscience, 2003
- PAIN MECHANISMS: Labeled Lines Versus Convergence in Central ProcessingAnnual Review of Neuroscience, 2003
- Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophreniaBiological Psychiatry, 2002
- Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophreniaProceedings of the National Academy of Sciences, 2001
- Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primateJournal of Comparative Neurology, 2001
- Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatumJournal of Comparative Neurology, 2000
- Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeysNeuroReport, 1994
- Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatumNeuroscience, 1993